65 D. Medaglini et al., “Mucosal and Systemic Immune Responses to a Recombinant Protein Expressed on the Surface of the Oral Commensal Bacterium Streptococcus gordonii After Oral Colonization”, Proceedings of the National Academy of Sciences 92 (1995), 6868–6872.

66 Ashu Sharma et al., “Oral Immunization with Recombinant Streptococcus gordonii Expressing Porphyromonas gingivalis FimA Domains”, Infection and Immunity 69 (2001), 2928–2934.

67 Corinne Grangette et al., “Protection Against Tetanus Toxin After Intragastric Administration of Two Recombinant Lactic Acid Bacteria: Impact of Strain Viability7 and In Vitro Persistence”, Vaccine 20 (2002), 3304–3309; B. Corthesy et al., “Oral Immunization of Mice with Lactic Acid Bacteria Producing Helicobacter pylori Urease B Subunit Partially Protects Against Challenge with Helicobacter felis”, Journal of Infectious Diseases 192 (2005), 1441–1449.

68 L. Scheppler et al., “Intranasal Immunisation Using Recombinant Lactobacill johnsonii as a New Strategy to Prevent Allergic Disease”, Vaccine 9 (2005), 1126–1134.

69 Scheppler et al., “Intranasal Immunisation Using Recombinant Lactobacillus johnsonii”; B. Stadler et al., “Lactic Acid Bacteria as Agents for Preventing Allergy”, заявка на патент США № 200402655290.